Trimbow (beclometasone/formoterol/glycopyrrolate) - Chiesi
Early versus late escalation to extrafine BDP/FF/GB single-inhaler triple therapy in COPD: a real-world subgroup analysis by disease duration since diagnosis. (PubMed, Respir Med) - Oct 6, 2026 - "Early escalation to SITT in COPD may result in more durable sustained clinical benefits compared with later intervention, reducing exacerbations and maintaining disease stability and control up to 12 months." 
Journal • Real-world evidence • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42833477
 
Alessio Piraino; Daiana Stolz; Elena Nudo; Guy Brusselle; Laura Franzini; Luca Di Palma; Paola Rogliani; Petros Bakakos
 
Oct 6, 2026
 
Prev Next